Azacitidine, Lenalidomide and DLI as Salvage Therapy for MDS, CMML and sAML Relapsing After Allo-HSCT
Clinical trial NCT02472691 · COMPLETED
Trial details
- NCT number
- NCT02472691
- Sponsor
- Heinrich-Heine University, Duesseldorf
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2020-04-23
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.